Virpax Pharmaceuticals, Inc. — Form D
Virpax Pharmaceuticals, Inc. of BERWYN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-12. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-12
- Form: D
- Accession: 0001213900-24-061018
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 1
- Date of first sale: 2024-07-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-518634
Issuer
- Name: Virpax Pharmaceuticals, Inc.
- CIK: 0001708331
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1055 WESTLAKES DRIVE, SUITE 300, BERWYN, PA, 19312
- Phone: (610) 727-4597
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Gerald Bruce | Director | Berwyn, PA |
| Jatinder M Dhaliwal | Director | Berwyn, PA |
| Katharyn M Field | Director | Berwyn, PA |
| Eric Floyd | Director | Berwyn, PA |
| Gary M Herman | Director | Berwyn, PA |
| Vanila M Singh | Director | Palo Alto, CA |
| Judy M Su | Director | Berwyn, PA |
| Gerald Bruce | Executive Officer | Berwyn, PA |
| Sheila M Mathias | Executive Officer | Berwyn, PA |
| Vinay Shah | Executive Officer | New York, NY |
| Thani Jambulingam | Director | Malvern, PA |
| Anthony Mack | Director | Malvern, PA |
| Anthony Mack | Executive Officer | Malvern, PA |
| Jeffrey Gudin | Director | Malvern, PA |
| Jeffrey Gudin | Executive Officer | Malvern, PA |
| Jerrold Sendrow | Director | Malvern, PA |
Other filings by this issuer (1)
More